
    
      This is a single center, proof of concept prospective cohort trial designed to assess the
      effect of daily oral administration of dapagliflozin on cystine formation in freshly voided
      urine. Five subjects are planned, each with previously diagnosed cystinuria and without
      current treatment except with potassium citrate medication.

      Total duration of subject participation with be up to four weeks. Total duration of the study
      is expected to be 6 months.
    
  